Transplantation rénale : réalisation et complications

No abstract is available for this paper.

• Publication year

  2006

• Venue

  EMC - Néphrologie

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S1762-0945(07)25192-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mycoses profondes et transplantations des organes solides

  2008cited by this paper
• Severe Diarrhea in Renal Transplant Patients: Results of the DIDACT Study

  2006cited by this paper
• Association of kidney transplant failure and antibodies against MICA.

  2006cited by this paper
• HIV-Positive Renal Recipients Can Achieve Survival Rates Similar to Those of HIV-Negative Patients

  2006cited by this paper
• Long-term outcome of renal transplantation from older donors.

  2006cited by this paper
• The Kidney: Imaging with Microbubble Contrast Agents

  2006cited by this paper
• Surmonter les barrières classiques des groupes sanguins abo en transplantation d'organe

  2006cited by this paper
• Mycophenolate sodium-induced hepatotoxicity: first report.

  2006cited by this paper
• Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.

  2006cited by this paper
• The emerging role of rituximab in organ transplantation

  2006cited by this paper
• Donor Nephrectomy: Mini-Incision Muscle-Splitting Open Approach versus Laparoscopy

  2006cited by this paper
• A Cluster of Parvovirus B19 Infections in Renal Transplant Recipients: A Prospective Case Series and Review of the Literature

  2006cited by this paper
• Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.

  2005cited by this paper
• A prospective randomized study for prevention of postrenal transplantation bone loss.

  2005cited by this paper
• Malignancy after Transplantation

  2005cited by this paper
• Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients.

  2005cited by this paper
• Non–Heart-Beating Donor Kidneys in The Netherlands: Allocation and Outcome of Transplantation

  2005cited by this paper
• Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage

  2005cited by this paper
• Strategies for improving long-term survival in patients with ESRD.

  2005cited by this paper
• Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

  2005cited by this paper
• Humoral Rejection of Organ Allografts

  2005cited by this paper
• Benefits of Erythropoietin in Renal Transplantation

  2005cited by this paper
• Benefit-Risk Assessment of Sirolimus in Renal Transplantation

  2005cited by this paper
• Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction

  2005cited by this paper
• The kidney as a determinant of genetic hypertension: evidence from renal transplantation studies.

  2005cited by this paper
• New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation.

  2005cited by this paper
• Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods.

  2005cited by this paper
• Hypertension in kidney transplantation.

  2005cited by this paper
• Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations

  2005cited by this paper
• Successful Renal Retransplantation after Post‐Transplant Lymphoproliferative Disease

  2004cited by this paper
• Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies?

  2004cited by this paper
• The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome.

  2004cited by this paper
• Renal-Transplant Recipients and Sun Protection

  2004cited by this paper
• Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature

  2004cited by this paper
• Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

  2004cited by this paper
• Immunosuppressive drugs for kidney transplantation.

  2004cited by this paper
• Histopathologic Efficacy of Ribavirin Monotherapy in Kidney Allograft Recipients with Chronic Hepatitis C

  2004cited by this paper
• Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation

  2003cited by this paper
• New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.

  2003cited by this paper
• Chronic allograft nephropathy

  2003cited by this paper
• Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection

  2003cited by this paper
• Multivariate analysis of donor risk factors for graft survival in kidney transplantation

  2003cited by this paper
• Ten-year survival of second kidney transplants: impact of immunologic factors and renal function at 12 months.

  2003cited by this paper
• Skin cancers after organ transplantation.

  2003cited by this paper
• Management of chronic viral hepatitis before and after renal transplantation

  2002cited by this paper
• Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study.

  2002cited by this paper
• Acute graft pyelonephritis and long-term kidney allograft outcome.

  2002cited by this paper
• Non‐melanoma skin cancer risk in the Queensland renal transplant population

  2002cited by this paper
• Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment

  2002cited by this paper
• Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet1

  2002cited by this paper
• Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection.

  2002cited by this paper
• The pathophysiology of diarrhea

  2001cited by this paper
• HYPERLIPIDEMIA AND CARDIOVASCULAR DISEASE AFTER ORGAN TRANSPLANTATION

  2001cited by this paper
• Immunosuppressive therapy and post‐transplantation diarrhea

  2001cited by this paper
• Cytomegalovirus in solid organ transplantation

  2001cited by this paper
• Factor V Leiden mutation: potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis

  2001cited by this paper
• Long-term survival in renal transplant recipients with graft function.

  2000cited by this paper
• Safety and efficacy of granulocyte colony‐stimulating factor in kidney and liver transplant recipients

  2000cited by this paper
• Cigarette smoking in renal transplant recipients.

  2000cited by this paper
• Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

  1999cited by this paper
• The Banff 97 working classification of renal allograft pathology.

  1999cited by this paper
• Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF).

  1999cited by this paper
• Impact of HLA system on organ transplantation: a critical review before the end of the millennium.

  1999cited by this paper
• Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients.

  1998cited by this paper
• Lesions in donor kidneys: nature, incidence, and influence on graft function

  1998cited by this paper
• Infection in organ-transplant recipients.

  1998cited by this paper
• Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection - A report of the European Tacrolimus Multicenter Renal Study Group

  1997cited by this paper
• Bilateral nephrectomy simultaneously with renal allografting does not alleviate hypertension 3 months following living-donor transplantation.

  1996cited by this paper
• Double renal allografts successfully increase utilization of kidneys from older donors within a single organ procurement organization.

  1996cited by this paper
• Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families.

  1996cited by this paper
• Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?

  1995cited by this paper
• GLOMERULOSCLEROSIS AS A DETERMINANT OF POSTTRANSPLANT FUNCTION OF OLDER DONOR RENAL ALLOGRAFTS

  1995cited by this paper
• Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients.

  1995cited by this paper
• Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study.

  1994cited by this paper
• Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation.

  1994cited by this paper
• Hypertension following kidney transplantation.

  1994cited by this paper
• [Viral hepatitis in hemodialysis and renal transplantation patients].

  1994cited by this paper
• The effect of immunosuppression on pre-existing cancers.

  1993cited by this paper
• Infectious disease complications of renal transplantation.

  1993cited by this paper
• International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.

  1993cited by this paper
• Absence of hepatitis delta virus infection in chronic hemodialysis and kidney transplant patients in france.

  1992cited by this paper
• Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation.

  1992cited by this paper
• Hepatitis C virus in kidney recipients

  1992cited by this paper
• Recurrent diseases in the renal allograft.

  1991cited by this paper
• Morphologic findings in "zero-hour" biopsies of renal transplants.

  1991cited by this paper
• Is renal transplantation useful for the understanding of the pathogenesis of hypertension?

  1990cited by this paper
• Incidence of skin cancer after renal transplantation in The Netherlands.

  1990cited by this paper
• Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation.

  1989cited by this paper
• Hypertension in renal transplantation.

  1988cited by this paper
• Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life.

  1988cited by this paper
• Risk factors for accelerated atherosclerosis in renal transplant recipients.

  1988cited by this paper
• The benefit of exchanging donor kidneys among transplant centers.

  1988cited by this paper
• Improved kidney graft survival in nontransfused recipients.

  1987cited by this paper
• Hepatitis in renal transplant recipients.

  1987cited by this paper
• Hypertension in renal transplant recipients

  1987cited by this paper
• Successful renal transplantation in patients with T-cell reactivity to donor.

  1982cited by this paper
• Cytomegalovirus Disease in Renal Allograft Recipients: A Prospective Study of the Clinical Features, Risk Factors and Impact on Renal Transplantation

  1980cited by this paper
• Factors contributing to the declining mortality rate in renal transplantation.

  1978cited by this paper
• Significance of the positive crossmatch test in kidney transplantation.

  1969cited by this paper
• FEMORAL NECK FRACTURES.

  1964cited by this paper

• Suivi immunologique en transplantation rénale : 13 ans d’expérience d’un laboratoire d’histocompatibilité marocain

  2016cites this paper
• [Immunological monitoring in kidney transplantation: 13 years experience of a Moroccan histocompatibility laboratory].

  2016cites this paper